Articular involvement in antiphospholipid syndrome: Clinical, laboratory, and imaging characterization
Maria Ester Simeira Fonseca Ribeiro, Flavio Signorelli, Gustavo Guimarães Moreira Balbi, Karina Rossi Bonfiglioli, João Carlos Rodrigues, Lissiane Karine Noronha Guedes, Danieli Castro Oliveira de AndradeIntroduction
Antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies (aPL) and thrombotic and/or obstetric events. Musculoskeletal manifestations, particularly arthralgia, are frequently reported, although their clinical and pathophysiological correlates remain incompletely characterized.
Objective
To characterize the clinical, laboratory, and imaging features of articular involvement in primary and systemic lupus erythematosus (SLE)-associated APS compared with healthy controls.
Methods
This cross-sectional study included 99 participants aged 18–50 years: 38 with primary APS (PAPS), 26 with APS associated with SLE (APS/SLE), and 35 age- and sex-matched healthy controls. APS patients fulfilled the Sydney classification criteria, and those with SLE were classified according to the 1997 American College of Rheumatology criteria. Arthralgia was clinically assessed. Radiographic and high-resolution ultrasound (US) evaluation of the hands and wrists was performed. Laboratory tests included erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), and anti-cyclic citrullinated peptide (anti-CCP) antibodies.
Results
Age was comparable across groups (
Conclusion
Articular manifestations are common in APS, particularly in APS/SLE, but are not consistently supported by objective evidence of inflammation. This dissociation suggests that musculoskeletal involvement may not be primarily mediated by overt inflammatory mechanisms.